An observational study in Attention Deficit Hyperactivity Disorder, Depression and Anxiety, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-03.
Sponsored by Assiut University · Observational
Among 13 studies in Attention Deficit Disorder with Hyperactivity by Assiut University — 8 open to participants now, 8 under way, none of them phase 3. Attention Deficit Disorder with Hyperactivity · Assiut University.
Among the 13 studies in Attention Deficit Disorder with Hyperactivity by Assiut University, this one is the 8th largest by planned enrollment of the 10 observational ones that give a count, is one of 4 that started in 2026, is one of 10 observational ones, and was the 12th registered.
1,817 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 295 are open to participants now.
Browse Attention Deficit Disorder with Hyperactivity studies →8 of the 13 studies in Attention Deficit Disorder with Hyperactivity by Assiut University are open now. Recruiting first, the newest first:
Assiut University
Ages 3–16
Assiut University
Ages 3–18
Assiut University
Ages 6–19 · Healthy volunteers
Assiut University
Ages 6–18
Assiut University
Ages 6–18 · Healthy volunteers
Of the 201 Attention Deficit Disorder with Hyperactivity studies recruiting now, 27 (13%) set no upper age limit and 169 (84%) stop at 75 or younger; 141 take children under 18; 55 take healthy volunteers.
This study: 18 Years and older · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 4 started in 2026.
This study's planned enrollment of 52 is below the median of 127 across 329 observational studies indexed under Attention Deficit Disorder with Hyperactivity.
Median enrollment 80 across the 3 interventional studies, 92 across the 10 observational. Of the 2 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Assiut University is the lead sponsor of 5,079 studies on the registry; 2,177 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
4 of the studies in Attention Deficit Disorder with Hyperactivity by Assiut University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07315217Assiut UniversityCortical Excitability and Role of Non Invasive Brain Stimulation in ADHD and AUTISM | 2027-01 |
| NCT07205211Assiut UniversityPrevalence of ADHD in Children With Epilepsy | 2027-01-01 |
| NCT07858448Assiut UniversityCardiovascular Safety of Atomoxetine in Children With ADHD | 2027-09-30 |
| NCT07803224Assiut UniversityAdult ADHD Symptoms, Depression, Anxiety, and Academic Performance in Medical Students | 2027-10 |
Add all 4 to your calendar (.ics) → With an account.
Among the 13 studies in Attention Deficit Disorder with Hyperactivity by Assiut University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Attention-deficit/hyperactivity disorder (ADHD) is increasingly recognized to persist into adulthood, often impacting academic performance in university and professional education. This relationship may be further complicated by co-occurring mental health conditions, such as depression and anxiety.
The purpose of this cross-sectional study is to determine the prevalence of adult ADHD symptoms, depressive symptoms, and anxiety symptoms among undergraduate medical students at Assiut University. The study also aims to evaluate how these psychiatric symptoms are associated with academic performance.
Participants will complete a series of self-administered questionnaires, including the Adult ADHD Self-Report Scale (ASRS v1.1), the Patient Health Questionnaire-9 (PHQ-9) for depression, the Generalized Anxiety Disorder-7 (GAD-7) scale for anxiety, a socioeconomic status scale, and demographic/academic information including cumulative grade point average (GPA).
The study population consists of undergraduate medical students aged 18 years or older who are currently enrolled at the Faculty of Medicine, Assiut University, Egypt.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Undergraduate medical students aged 18 years or older enrolled at the Faculty of Medicine, Assiut University, who complete self-administered questionnaires assessing adult ADHD symptoms (ASRS v1.1), depressive symptoms (PHQ-9), anxiety symptoms (GAD-7), socioeconomic status, and academic performance (cumulative GPA).
Percentage of Participants Screening Positive for Adult ADHD Symptoms
Assessed using the 6-item Adult ADHD Self-Report Scale (ASRS v1.1) Arabic version. The scale evaluates the frequency of inattention and hyperactivity/impulsivity symptoms over the preceding 6 months. Each item is rated on a 5-point scale (never, rarely, sometimes, often, very often). A positive screen is defined by meeting the established clinical cutoff threshold (responses falling within shaded/clinically significant boxes), indicating a high likelihood of adult ADHD symptoms.
Time frame: Baseline
No study locations are listed for this record.
Start is estimated for Oct 2026; primary completion for Oct 2027, 12 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Attention Deficit Disorder with Hyperactivity →